Cargando…
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haemat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595141/ https://www.ncbi.nlm.nih.gov/pubmed/26445238 http://dx.doi.org/10.1186/s13045-015-0209-2 |
_version_ | 1782393546730373120 |
---|---|
author | Noll, Jacqueline E. Vandyke, Kate Hewett, Duncan R. Mrozik, Krzysztof M. Bala, Rachel J. Williams, Sharon A. Kok, Chung H. Zannettino, Andrew CW |
author_facet | Noll, Jacqueline E. Vandyke, Kate Hewett, Duncan R. Mrozik, Krzysztof M. Bala, Rachel J. Williams, Sharon A. Kok, Chung H. Zannettino, Andrew CW |
author_sort | Noll, Jacqueline E. |
collection | PubMed |
description | BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haematopoietic compartment of the myeloma-susceptible C57BL/KaLwRij mouse strain, when compared with the myeloma-resistant C57BL/6 mouse. Over-expression of PTTG1 has previously been associated with malignant progression and an enhanced proliferative capacity in solid tumours. METHODS: In this study, we investigated PTTG1 gene and protein expression in MM plasma cells from newly diagnosed MM patients. Gene expression profiling was used to identify gene signatures associated with high PTTG1 expression in MM patients. Additionally, we investigated the effect of short hairpin ribonucleic acid (shRNA)-mediated PTTG1 knockdown on the proliferation of the murine myeloma plasma cell line 5TGM1 in vitro and in vivo. RESULTS: PTTG1 was found to be over-expressed in 36–70 % of MM patients, relative to normal controls, with high PTTG1 expression being associated with poor patient outcomes (hazard ratio 2.49; 95 % CI 1.28 to 4.86; p = 0.0075; log-rank test). In addition, patients with high PTTG1 expression exhibited increased expression of cell proliferation-associated genes including CCNB1, CCNB2, CDK1, AURKA, BIRC5 and DEPDC1. Knockdown of Pttg1 in 5TGM1 cells decreased cellular proliferation, without affecting cell cycle distribution or viability, and decreased expression of Ccnb1, Birc5 and Depdc1 in vitro. Notably, Pttg1 knockdown significantly reduced MM tumour development in vivo, with an 83.2 % reduction in tumour burden at 4 weeks (p < 0.0001, two-way ANOVA). CONCLUSIONS: This study supports a role for increased PTTG1 expression in augmenting tumour development in a subset of MM patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-015-0209-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4595141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45951412015-10-07 PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma Noll, Jacqueline E. Vandyke, Kate Hewett, Duncan R. Mrozik, Krzysztof M. Bala, Rachel J. Williams, Sharon A. Kok, Chung H. Zannettino, Andrew CW J Hematol Oncol Research BACKGROUND: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the haematopoietic compartment of the myeloma-susceptible C57BL/KaLwRij mouse strain, when compared with the myeloma-resistant C57BL/6 mouse. Over-expression of PTTG1 has previously been associated with malignant progression and an enhanced proliferative capacity in solid tumours. METHODS: In this study, we investigated PTTG1 gene and protein expression in MM plasma cells from newly diagnosed MM patients. Gene expression profiling was used to identify gene signatures associated with high PTTG1 expression in MM patients. Additionally, we investigated the effect of short hairpin ribonucleic acid (shRNA)-mediated PTTG1 knockdown on the proliferation of the murine myeloma plasma cell line 5TGM1 in vitro and in vivo. RESULTS: PTTG1 was found to be over-expressed in 36–70 % of MM patients, relative to normal controls, with high PTTG1 expression being associated with poor patient outcomes (hazard ratio 2.49; 95 % CI 1.28 to 4.86; p = 0.0075; log-rank test). In addition, patients with high PTTG1 expression exhibited increased expression of cell proliferation-associated genes including CCNB1, CCNB2, CDK1, AURKA, BIRC5 and DEPDC1. Knockdown of Pttg1 in 5TGM1 cells decreased cellular proliferation, without affecting cell cycle distribution or viability, and decreased expression of Ccnb1, Birc5 and Depdc1 in vitro. Notably, Pttg1 knockdown significantly reduced MM tumour development in vivo, with an 83.2 % reduction in tumour burden at 4 weeks (p < 0.0001, two-way ANOVA). CONCLUSIONS: This study supports a role for increased PTTG1 expression in augmenting tumour development in a subset of MM patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-015-0209-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-06 /pmc/articles/PMC4595141/ /pubmed/26445238 http://dx.doi.org/10.1186/s13045-015-0209-2 Text en © Noll et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Noll, Jacqueline E. Vandyke, Kate Hewett, Duncan R. Mrozik, Krzysztof M. Bala, Rachel J. Williams, Sharon A. Kok, Chung H. Zannettino, Andrew CW PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title_full | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title_fullStr | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title_full_unstemmed | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title_short | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
title_sort | pttg1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595141/ https://www.ncbi.nlm.nih.gov/pubmed/26445238 http://dx.doi.org/10.1186/s13045-015-0209-2 |
work_keys_str_mv | AT nolljacquelinee pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT vandykekate pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT hewettduncanr pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT mrozikkrzysztofm pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT balarachelj pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT williamssharona pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT kokchungh pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma AT zannettinoandrewcw pttg1expressionisassociatedwithhyperproliferativediseaseandpoorprognosisinmultiplemyeloma |